1. Allen H, Zelenski J. 430 Non-hospitalized thyroid cancer patients treated with single doses of 40–400 mCi (abstract). J Nucl Med. 1992;33:784.
2. Beckers C. Regulations and policies in radiodine 131I therapy in Europe. Thyroid. 1997;7:221–4.
3. IAEA. Release of patients after radionuclide therapy. Safety Report Series 63. Vienna, Austria: International Atomic Energy Agency (IAEA); 2009.
4. Vetter RJ. Regulations for radioiodine therapy in the United States: current status and the process of change. Thyroid. 1997;7:209–11.
5. ICRP. Release of patients after radionuclide therapy with unsealed radionuclides. International Commission on Radiological Protection (ICRP) publication 94. Oxford: Elsevier; 2004.